Literature DB >> 31264916

Homozygous and heterozygous retinal phenotypes in families harbouring IMPG2 mutations.

Arif O Khan1,2, Amal M Al Teneiji3.   

Abstract

Introduction: Biallelic mutations in interphotoreceptor matrix proteoglycan 2 (IMPG2) have been shown to underlie recessive childhood-onset rod-cone dystrophy with early macular involvement in several families. In other families, heterozygous IMPG2 mutations have been associated with dominant vitelliform macular dystrophy. To date, the retinal phenotype of heterozygotes from families with recessive IMPG2-related retinal dystrophy has not been assessed. This study documents the genotypes and phenotypes observed in both homozygotes and available heterozygotes from additional families with IMPG2-related recessive rod-cone dystrophy.
Methods: Retrospective case series (2016-2018).
Results: Four families were identified. All were first-cousin marriages and had no known relation to each other. Individuals with biallelic pathogenic variants (7 individuals) had childhood-onset rod-cone dystrophy. Families 1 and 2 harboured the same novel homozygous mutation c.189dup;p.Gln64Thrfs*9 (5 individuals, 4-17 years old). Family 3 harboured the novel homozygous mutation c.533 + 4_533 + 7del;p.? (1 individual, 17 years old), and Family 4 harboured the previously reported homozygous mutation c.3262C>T;p.Arg1088* (1 individual, 45 years old). The 3 available carriers were genetically confirmed (both parents from Family 1 and the father from Family 3) and had macular focal retinal pigment epithelium thickening by optical coherence tomography (OCT). The father from Family 3 also had unilateral sectoral pigmentary retinopathy. Conclusions: Childhood-onset recessive rod-cone dystrophy with early macular involvement should prompt examination of the parents for macular focal retinal pigment epithelium thickening on OCT. If present the possibility of biallelic IMPG2 mutations in the proband should be considered. Young affected relatives of the proband can show multimodal imaging abnormalities before they are overtly symptomatic.

Entities:  

Keywords:  IMPG2; Retina; heterozygous; homozygous

Mesh:

Substances:

Year:  2019        PMID: 31264916     DOI: 10.1080/13816810.2019.1627467

Source DB:  PubMed          Journal:  Ophthalmic Genet        ISSN: 1381-6810            Impact factor:   1.803


  7 in total

1.  Clinical and genetic investigations in Chinese families with retinitis pigmentosa.

Authors:  Ling Chen; Ningli Wang; Mingying Lai; Fei Hou; Jing He; Xianming Fan; Xue Yao; Ruijuan Wang
Journal:  Exp Biol Med (Maywood)       Date:  2022-04-11

2.  Proteoglycan IMPG2 Shapes the Interphotoreceptor Matrix and Modulates Vision.

Authors:  Ezequiel M Salido; Visvanathan Ramamurthy
Journal:  J Neurosci       Date:  2020-04-07       Impact factor: 6.167

3.  The genetics of rod-cone dystrophy in Arab countries: a systematic review.

Authors:  Hawraa Joumaa; Zamzam Mrad; Lama Jaffal; Christina Zeitz; Isabelle Audo; Said El Shamieh
Journal:  Eur J Hum Genet       Date:  2020-11-13       Impact factor: 5.351

4.  Different Phenotypes in Pseudodominant Inherited Retinal Dystrophies.

Authors:  Imen Habibi; Yosra Falfoul; Hoai Viet Tran; Khaled El Matri; Ahmed Chebil; Leila El Matri; Daniel F Schorderet
Journal:  Front Cell Dev Biol       Date:  2021-02-05

5.  IMPG2-associated unilateral adult onset vitelliform macular dystrophy.

Authors:  Michalis Georgiou; Muhammad Z Chauhan; Michel Michaelides; Sami H Uwaydat
Journal:  Am J Ophthalmol Case Rep       Date:  2022-09-06

6.  Interphotoreceptor matrix proteoglycans IMPG1 and IMPG2 proteolyze in the SEA domain and reveal localization mutual dependency.

Authors:  Benjamin Mitchell; Chloe Coulter; Werner J Geldenhuys; Scott Rhodes; Ezequiel M Salido
Journal:  Sci Rep       Date:  2022-09-15       Impact factor: 4.996

7.  A LINE-1 insertion situated in the promoter of IMPG2 is associated with autosomal recessive progressive retinal atrophy in Lhasa Apso dogs.

Authors:  Rebekkah J Hitti-Malin; Louise M Burmeister; Sally L Ricketts; Thomas W Lewis; Louise Pettitt; Mike Boursnell; Ellen C Schofield; David Sargan; Cathryn S Mellersh
Journal:  BMC Genet       Date:  2020-09-07       Impact factor: 2.797

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.